Drugs / QazCoVac-P
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04930003 | Jun → Dec 2021 | COVID-19 | Research Institute for Biological Safety Problems | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QazCoVac-P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04930003 ↗ |
| Modality | Vaccine | “QazCoVac-P -COVID-19 Subunit Vaccine” NCT04930003 ↗ |
| Route | Intramuscular | “intramuscularly” NCT04930003 ↗ |